POSB99 The Cost-Effectiveness of Biologic/Targeted Synthetic/Biosimilar Disease Modifying Antirheumatic Drugs: A Systematic Review
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.372
https://www.valueinhealthjournal.com/article/S1098-3015(21)02167-7/fulltext
Title :
POSB99 The Cost-Effectiveness of Biologic/Targeted Synthetic/Biosimilar Disease Modifying Antirheumatic Drugs: A Systematic Review
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02167-7&doi=10.1016/j.jval.2021.11.372
First page :
Section Title :
Open access? :
No
Section Order :
11151